Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 2,214

Document Document Title
WO/2012/043622
Provided is a process for producing an optically active amino compound, which is a compound useful as an intermediate for a medicine, an agrochemical or the like, from a ketone compound with high efficiency. A polypeptide which has high ...  
WO/2012/043653
Provided is a method for economically and efficiently producing an optically active amino compound, which is useful as an intermediate for drugs, pesticides and so on, from a ketone compound. A novel polypeptide having a transaminase act...  
WO/2012/029819
The purpose of the present invention is to provide a novel hydrolase which can be used for efficiently producing a (1S,2S)-1-alkoxycarbonyl-2-vinylcyclopropanecarboxylic acid, which is a compound useful as an intermediate for the synthes...  
WO/2012/014953
A process for efficiently producing an optically active succinimide derivative which is a key intermediate for the production of (3R)-2'-(4-bromo-2-fluorobenzyl)spiro[pyrrolidine-3,4'(1'H)- pyrrolo[1,2-a]pyrazine]-1',2,3',5(2'H)-tetraone...  
WO/2012/007445
This invention describes the use of mutarotase (also known as aldose-1-epimerase) in a process for carbohydrate crystallization. Preferably the carbohydrate is a reducing sugar, more preferably the carbohydrate is lactose. The mutarotase...  
WO/2012/001305
The present invention relates to a method for continuous regeneration of NADH from NAD+ by means of formate (HCO2 -) and a formate dehydrogenase enzyme FDH immobilized within a grafted polymer. It also relates to a system for detection o...  
WO/2012/002450
Disclosed is a novel D-succinylase which has high hydrolytic activity on N-succinyl-D-amino acid and is capable of producing D-amino acid with high yield on an industrial scale and in a period of time suitable for commercial production w...  
WO/2012/001305
The present invention relates to a method for continuous regeneration of NADH from NAD+ by means of formate (HCO2 -) and a formate dehydrogenase enzyme FDH immobilized within a grafted polymer. It also relates to a system for detection o...  
WO/2011/118450
Disclosed is a method for manufacturing an optically active N-methyl amino acid and/or an optically active N-methyl amino acid amide by using a fungal body of a microorganism belonging to the Mycoplana genus, or a substance obtained by p...  
WO/2011/106546
Processes utilizing treatment with Candida Antarctica lipase B ("CAL-B") or Candida Antarctica lipase A ("CAL-A") for desymmetiϊzation of a prochiral di-ester compound of formula (I): wherein R is a C1-C4 alkyl group, R1 is a hydrogen; ...  
WO/2011/100265
The present disclosure relates to the use of an amino acid dehydrogenase in combination with a cofactor regenerating system comprising a ketoreductase. In particular embodiments, the process can be used to prepare L-tert-leucine using a ...  
WO/2011/100265
The present disclosure relates to the use of an amino acid dehydrogenase in combination with a cofactor regenerating system comprising a ketoreductase. In particular embodiments, the process can be used to prepare L-tert-leucine using a ...  
WO/2011/092345
The present invention relates to a novel enzymatically catalyzed method for the production of asymmetric aromatic aldehydes in an aqueous reaction medium containing certain organic co-solvents.  
WO/2011/078172
A process for producing an optically active 3-substituted glutaric acid monoamide, characterized by mixing a mixed solution of an optically active 3-substituted glutaric acid monoamide represented by formula (2) (wherein * represents an ...  
WO/2011/071058
Disclosed is an efficient industrial preparation method for an optically active 2-hydroxycycloalkane carboxylic acid ester that is useful as an intermediate for the production of pharmaceutical products. Specifically disclosed is a metho...  
WO/2011/068206
Disclosed is a process for producing D- or L-tert-leucine or D- or L-tert-leucineamide by reacting DL-tert-leucineamide with a biological catalyst selected from the group consisting of an enzyme capable of hydrolyzing DL-tert-leucineamid...  
WO/2011/066755
A process for preparing ethyl (3R, 5S)-dihydroxy-6-benzyloxy hexanoate via stereoselective microbial reduction is provided, which includes that ethyl 3,5-diketo-6-benzyloxy hexanoate is used as a substrate and a diketoreductase is used a...  
WO/2011/040700
The present invention relates to a method for producing alkyl lactate directly from ammonium lactate generated in a fermentation process. In detail, the present invention relates to a method for producing alkyl lactate directly from ammo...  
WO/2011/040700
The present invention relates to a method for producing alkyl lactate directly from ammonium lactate generated in a fermentation process. In detail, the present invention relates to a method for producing alkyl lactate directly from ammo...  
WO/2011/036233
The invention relates to a method for producing optically active 3-amino carboxylic acid ester compounds of general formula I, and the ammonium salts thereof, where R1 is alkyl, alkoxyalkyl, alkenyl, cycloalkyl, heterocycloalkyl, aryl, o...  
WO/2011/034126
A process for preparing an optically active equol enantiomer using daidzein as the starting substance, characterized by including a step of conducting optical resolution that relies on asymmetric esterification by a lipase. By the proces...  
WO/2011/013340
Disclosed is a method for producing an optically active 3-substituted glutaric acid monoamide by subjecting a prochiral 3-substituted glutaric acid diamide to the action of an enzyme source which asymmetrically hydrolyzes prochiral 3-sub...  
WO/2010/151593
Stereospecific carbonyl reductases SCR1, SCR2, and SCR3 are described herein as are nucleotide sequences that encode these reductases. These stereospecific carbonyl reductases have anti-Prelog selectivity and have specificities that are ...  
WO/2010/151593
Stereospecific carbonyl reductases SCR1, SCR2, and SCR3 are described herein as are nucleotide sequences that encode these reductases. These stereospecific carbonyl reductases have anti-Prelog selectivity and have specificities that are ...  
WO/2010/134642
Disclosed is a method for preparing a protein complex comprising a first step for concentrating crude plant and animal proteins, a second step for entrapping said crude proteins in calcium alginate gel and causing aerial oxidizing before...  
WO/2010/123067
Disclosed is a process for producing an (S)-1-substituted propan-1-ol derivative which is a compound useful as an intermediate for the production of pharmaceutical agents, particularly (S)-3-chloro-1-(2-thienyl)propan-1-ol, effectively a...  
WO/2010/111622  
WO/2010/111622
The disclosure relates to engineered amidase polypeptides and processes of using the polypeptides for chiral resolution of amino acid amide compounds. The disclosure further relates to the polynucleotides that encode the engineered amida...  
WO/2010/100195
The invention relates to a method for stereoselectively, in particular enantioselectively, and enzymatically reducing keto compounds to the corresponding chiral hydroxy compounds, wherein the keto compounds are reduced using an enantiose...  
WO/2010/098505
Disclosed is a deracemization reaction of a mandelic acid derivative utilizing a biocatalyst, which is a process for producing an optically active mandelic acid derivative. Specifically disclosed is a process for producing optically acti...  
WO/2010/081053
The present disclosure provides engineered transaminase enzymes having improved properties as compared to a naturally occurring wild-type transaminase enzyme. Also provided are polynucleotides encoding the engineered transaminase enzymes...  
WO/2010/081053
The present disclosure provides engineered transaminase enzymes having improved properties as compared to a naturally occurring wild-type transaminase enzyme. Also provided are polynucleotides encoding the engineered transaminase enzymes...  
WO/2010/068994
A process for producing one or more chemical compounds comprising the steps of providing a bioelectrochemical system having an anode and a cathode separated by a membrane, the anode and the cathode being electrically connected to each ot...  
WO/2010/067613
Disclosed is an L-succinyl aminoacylase comprising (a) a protein coded by a gene consisting of the base sequence disclosed in sequence no. 1; (b) a protein consisting of the amino acid sequence disclosed in sequence no. 2; (c) a protein ...  
WO/2010/068756
There is provided a process for manufacture of optically-active, 2-(acyloxymethyl)-1,3-oxathiolanes of Formula (I) comprising a preparation of a racemic compound and an enzyme-catalyzed kinetic resolution of the enantiomers. The inventio...  
WO/2010/064744
The present invention relates to a microbial mutant in which the gene encoding transcription activator or the gene encoding dihydroxyacetone kinase in a microorganism having the ability to produce 1,3 -propanediol using glycerol as a car...  
WO/2010/058577
Disclosed is a method for producing an unsaturated aminocarboxylic acid derivative, which is useful as a pharmaceutical raw material, at low cost. Specifically, an unsaturated aminocarboxylic acid derivative is produced by hydrolyzing a...  
WO/2010/053050
Disclosed is an O-alkylserine which is useful as a pharmaceutical intermediate. Also disclosed is a process for producing an N-benzyl-O-alkylserine, which is a compound useful for the production of the O-alkylserine, on an industrial sc...  
WO/2010/050516
Disclosed is a method for producing an L-amino acid by allowing L-succinylase to act on a mixture of N-succinyl amino acid enantiomers in the coexistence of N-acylamino acid racemase to specifically hydrolyze the L-form. In particular, ...  
WO/2010/004577
The present invention provides a novel process for the preparation of enantiomerically enriched γ-nitro acid used an intermediate for the preparation of Pregabalin and further conversion to Pregabalin.  
WO/2010/005003
Disclosed is a method for producing (1S,2R)-2-chloro-2-fluorocyclopropanecarboxylic acid with a high yield and high selectivity. Specifically disclosed is a method for producing (1S,2R)-2-chloro-2-fluorocyclopropanecarboxylic acid, where...  
WO/2009/158343
The present invention relates to a stereoselective enzymatic synthesis of (S) or (R)-iso-butyl-glutaric ester, an intermediate of S-Pregabalin.  
WO/2009/153325
In the present invention a desired enantiomer of a compound selected from the group consisting of 3-butyn-2-ol and 3-buten-2-ol can be prepared from a racemic mixture containing the desired enantiomer thereof by selective oxidation of th...  
WO/2009/141362
The present invention relates to processes for the preparation of 5-methyl-3-nitromethyl-hexanoic acid ester and its salts. Also disclosed are processes for the preparation of 5-methyl-3-nitromethyl-hexanoic acid salt and a process for t...  
WO/2009/141362
The present invention relates to processes for the preparation of 5-methyl-3-nitromethyl-hexanoic acid ester and its salts. Also disclosed are processes for the preparation of 5-methyl-3-nitromethyl-hexanoic acid salt and a process for t...  
WO/2009/121785
The invention relates to a method for enzymatic deracemization of enantiomer mixtures of secondary alcohols through a combination of oxidation and reduction reactions by way of stereoselective alcohol dehydrogenases and cofactors thereof...  
WO/2009/121785
The invention relates to a method for enzymatic deracemization of enantiomer mixtures of secondary alcohols through a combination of oxidation and reduction reactions by way of stereoselective alcohol dehydrogenases and cofactors thereof...  
WO/2009/118750
The present invention provides a stereoselective enzymatic process for the resolution of a mixture of (±)-cis-3-acetoxy-1-(4-methoxyphenyl)-4-(2-furanyl)-2- azetidinone, (±)-cis-3-acetoxy-1-(4-methoxyphenyl)-4-(2-thiophenyl)-2-az etidi...  
WO/2009/107821
The object is to achieve a novel domino-type reaction of a hydrolysis reaction and a decarboxylation reaction using an esterase ST0071 as a catalyst to thereby produce an optically active carboxylic acid such as an optically active α-ar...  
WO/2009/099140
Disclosed is a process for producing an optically active indoline-2-carboxylic acid or a derivative thereof, which is useful as a starting material for the synthesis of a pharmaceutical agent or the like, from an indoline-2-carboxylic ac...  

Matches 1 - 50 out of 2,214